FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development
The FDA has recently turned its attention to the growing use of artificial intelligence and machine learning in drug development.

The FDA has recently turned its attention to the growing use of artificial intelligence and machine learning in drug development.

A review of key decisions from the Supreme Court’s 2021-2022 term, including rulings on abortion, concealed carry, and regulatory authority.

This post considers the application of Lawrence Lessig’s New Chicago School approach to regulation to the prevention of concussions in football.

Today’s pandemic destabilized hospital care because hospitals were neither coordinated nor managed systemically in order to meet population demands.

A doctrine that essentially allows courts to strike down willy-nilly policies that they deem “major” undermines the federal government’s capacity to govern.

Social media poses an active health threat to many of its users, in a way that is akin to other regulated substances.

The ruling casts uncertainty over upcoming deadlines for vaccination compliance.
